Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GENB · against 1,372 other Healthcare companies
Ranked #142 of 1,373 · scores higher than 90% of peers · safety percentile 90
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)137 peers with a safety percentile of 80–89, including GENB · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | GENB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 0.14× | 0.24× | 62% | 33% | |
| BetaLower is better · 1,320 reported | Not reported | 0.53 | — | — | 33% |
| Current ratioHigher is better · 1,338 reported | 8.30× | 2.62× | 84% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 138 | 40.3B SEK (≈$4.0B) | 90 | 79 | |
| 139 | 2.3B USD | 90 | 25 | |
| 140 | 1.5B USD | 90 | 30 | |
| 141 | 4.0B CNY (≈$561M) | 90 | 33 | |
| 142 | 1.8B USD | 90 | 30 | |
| 143 | 1.1B USD | 90 | 50 | |
| 144 | 976M USD | 90 | 36 | |
| 145 | 6.5B CNY (≈$911M) | 90 | 62 | |
| 146 | 387M USD | 89 | 49 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score